|4Feb 6, 4:48 PM ET

Cahill Brian Joseph 4

4 · EAGLE PHARMACEUTICALS, INC. · Filed Feb 6, 2023

Insider Transaction Report

Form 4
Period: 2023-02-02
Cahill Brian Joseph
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-02-02$34.09/sh785$26,76130,086 total
Footnotes (1)
  • [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION